BDNF and GDNF were studied therapeutically in models of Parkinson disease (PD) (Rangasamy et al., 2010) and Huntington disease (HD) (Alberch et al., 2004), with loss of neurons that express TrkB and RET. Here, NTRK2 is linked to Parkinson disease.